Executives with deep experience in the life sciences, genomics, diagnostics and high technology join together to revolutionize genetic testing and drug development.
Founded in 2017 by Dr. Martin Schiller of the University of Nevada, Heligenics Inc. was established to realize the promise of the functional genome.
What the GigaAssay is and how it compares to other functional genomics products on the market as well as how the science is revolutionizing drug development, rescue & diagnostics.
Heligenics has been enthusiastically received by both institutional and individual investor communities. We also have strong marketing alliances across USA and Europe.
Our research staff look forward to developing a strategy with you to effect change in drug discovery, drug rescue and genetic testing
Reach out via email, or if you would like to speak with someone ‘live’, please call us during business hours.